This is consistent with evidence showing the presence of NLRP3-dependent inflammasome activation in AD brains and the deleterious effect of this pro-inflammatory cascade in animal models of AD (Heneka et al., 2013; Ising et al., 2019). This evidence concerns the gene NLRP3 and Alzheimer disease.